Full text
PDFPage 1032
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Armstrong B., Stevens N., Doll R. Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women. Lancet. 1974 Sep 21;2(7882):672–675. doi: 10.1016/s0140-6736(74)93258-9. [DOI] [PubMed] [Google Scholar]
- Ramirez A. J., Craig T. K., Watson J. P., Fentiman I. S., North W. R., Rubens R. D. Stress and relapse of breast cancer. BMJ. 1989 Feb 4;298(6669):291–293. doi: 10.1136/bmj.298.6669.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schyve P. M., Smithline F., Meltzer H. Y. Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue. Arch Gen Psychiatry. 1978 Nov;35(11):1291–1301. doi: 10.1001/archpsyc.1978.01770350017001. [DOI] [PubMed] [Google Scholar]
- Shafie S., Brooks S. C. Effect of prolactin on growth and the estrogen receptor level of human breast cancer cells (MCF-7). Cancer Res. 1977 Mar;37(3):792–799. [PubMed] [Google Scholar]
- Williams R. R., Feinleib M., Connor R. J., Stegens N. L. Case-control study of antihypertensive and diuretic use by women with malignant and benign breast lesions detected in a mammography screening program. J Natl Cancer Inst. 1978 Aug;61(2):327–335. [PubMed] [Google Scholar]